Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) causes significant mortality globally. The majority of patients experience resistance to systemic therapies and often undergo recurrence or disease progression even after aggressive local therapies. Management of HCC is determined by the extent and stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyakale, Nozipho, Filippi, Luca, Aldous, Colleen, Sathekge, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093680/
https://www.ncbi.nlm.nih.gov/pubmed/37046636
http://dx.doi.org/10.3390/cancers15071975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093680/
https://www.ncbi.nlm.nih.gov/pubmed/37046636
http://dx.doi.org/10.3390/cancers15071975

Ejemplares similares